The tumor microenvironment is the complex ecosystem that surrounds cancer cells and strongly shapes how tumors grow, spread and respond to therapy. It includes immune cells, blood vessels, fibroblasts, extracellular matrix, signaling molecules and metabolic conditions such as oxygen and nutrient levels.

Immune cells in this environment can both attack and support tumors. Cytotoxic T cells and natural killer cells can recognize and kill cancer cells, but tumors often recruit immunosuppressive cells such as regulatory T cells and myeloid derived suppressor cells. These cells, along with certain macrophages, release factors that blunt anti tumor immunity and help cancer cells evade immune detection.

Blood vessels in tumors are abnormal in structure and function. They are often leaky, disorganized and poorly perfused, creating regions of low oxygen. Hypoxia drives genetic and metabolic adaptations in cancer cells, promotes blood vessel growth and supports more aggressive, therapy resistant phenotypes. It also alters immune cell behavior and drug delivery.

Cancer associated fibroblasts remodel the extracellular matrix, secrete growth factors and create physical and biochemical barriers to immune cell infiltration and drug penetration. The stiff, altered matrix can promote invasion and metastasis.

Metabolic reprogramming is another key feature. Cancer cells and associated stromal cells compete for glucose, amino acids and lipids, generating local nutrient depletion and acidic conditions. These changes favor tumor survival and suppress effective immune responses.

Current research focuses on targeting multiple components of this microenvironment at once, aiming to normalize blood vessels, reprogram immune and stromal cells and remodel the matrix to improve the efficacy of immunotherapy, chemotherapy and radiotherapy.